Xu; Guozhang

Patent Applications and Registrations

Patent applications and USPTO patent grants for Xu; Guozhang.The latest application filed is for "bicyclic pyridine n-oxide derivatives useful as a factor xia inhibitors".

Company Profile

11.30.36

Xu; Guozhang - Chesterbrook PA
Xu; Guozhang - Bensalem PA
Xu; Guozhang - Langhorne PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic Pyridine N-oxide Derivatives Useful As A Factor Xia Inhibitors App 20220306632 - Xu; Guozhang ; et al.	2022-09-29
Quinazolin-4-one Derivatives Useful As Grk2 Inhibitors App 20220267298 - Xu; Guozhang ; et al.	2022-08-25
Phthalazin-1-one Derivatives Useful As Grk2 Inhibitors App 20220242850 - Xu; Guozhang ; et al.	2022-08-04
Fused Isoindolin-1-one Derivatives Useful As Grk2 Inhibitors App 20220220125 - Xu; Guozhang	2022-07-14
Isoindolin-1-one Derivatives Useful As Grk2 Inhibitors App 20220009906 - Xu; Guozhang ; et al.	2022-01-13
Glucopyranose Derivatives Useful As Sglt2 Inhibitors App 20210388016 - Xu; Guozhang	2021-12-16
Glucopyranose Derivatives Useful As Sglt2 Inhibitors App 20210388015 - Xu; Guozhang	2021-12-16
Indazole derivatives useful as glucagon receptor antagonists Grant 11,098,016 - Xu , et al. August 24, 2	2021-08-24
5,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators App 20210238170 - Xu; Guozhang ; et al.	2021-08-05
5-fluoro-c-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators Grant 11,014,917 - Xu , et al. May 25, 2	2021-05-25
Indazole Derivatives Useful As Glucagon Receptor Antagonists App 20200377462 - Xu; Guozhang ; et al.	2020-12-03
Benzocyclobutane derivatives useful as dual SGLT1 / SGLT2 modulators Grant 10,815,210 - Gaul , et al. October 27, 2	2020-10-27
5-fluoro-c-(aryl Or Heterocyclyl)-glycoside Derivatives Useful As Dual Sglt1 / Sglt2 Modulators App 20200291004 - Xu; Guozhang ; et al.	2020-09-17
Indazole derivatives useful as glucagon receptor antagonists Grant 10,774,048 - Xu , et al. Sept	2020-09-15
5-fluoro-C-(aryl or heterocyclyl)-glycoside derivatives useful as dual SGLT1 / SGLT2 modulators Grant 10,696,662 - Xu , et al. June 30, 2	2020-06-30
Benzocyclobutane Derivatives Useful As Dual Sglt1 / Sglt2 Modulators App 20190367469 - Gaul; Micheal ; et al.	2019-12-05
Indazole Derivatives Useful As Glucagon Receptor Antagonists App 20190218186 - Xu; Guozhang ; et al.	2019-07-18
Indole derivatives useful as glucagon receptor antagonists Grant 10,251,864 - Gaul , et al.	2019-04-09
Indazole derivatives useful as glucagon receptor antagonists Grant 10,214,493 - Gaul , et al. Feb	2019-02-26
5-fluoro-c-(aryl Or Heterocyclyl)-glycoside Derivatives Useful As Dual Sglt1 / Sglt2 Modulators App 20190055226 - Xu; Guozhang ; et al.	2019-02-21
Indazole derivatives useful as glucagon receptor antagonists Grant 10,000,473 - Gaul , et al. June 19, 2	2018-06-19
Indazole Derivatives Useful As Glucagon Receptor Antagonists App 20180065934 - Gaul; Micheal ; et al.	2018-03-08
Indazole Derivatives Useful As Glucagon Receptor Antagonists App 20180065955 - Gaul; Micheal ; et al.	2018-03-08
Indole Derivatives Useful As Glucagon Receptor Antagonists App 20180064686 - Gaul; Micheal ; et al.	2018-03-08
Biphenyl derivatives useful as glucagon receptor antagonists Grant 9,045,389 - Chakravarty , et al. June 2, 2	2015-06-02
Dual SGLT1/SGLT2 inhibitors Grant 9,012,412 - Gaul , et al. April 21, 2	2015-04-21
Dual Sglt1/sglt2 Inhibitors App 20140256657 - Gaul; Micheal ; et al.	2014-09-11
Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-.alpha. modulators Grant 8,796,256 - Bignan , et al. August 5, 2	2014-08-05
Picolinamido-propanoic acid derivatives useful as glucagon receptor antagonists Grant 8,748,624 - Chakravarty , et al. June 10, 2	2014-06-10
Aminothiazolones as estrogen related receptor-alpha modulators Grant 8,445,690 - Bignan , et al. May 21, 2	2013-05-21
Aminothiazolones as estrogen related receptor-alpha modulators Grant 8,426,604 - Bignan , et al. April 23, 2	2013-04-23
Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators Grant 8,399,681 - Bignan , et al. March 19, 2	2013-03-19
Substituted phenoxy thiazolidinediones as estrogen related receptor-a modulators Grant 8,344,009 - Gaul , et al. January 1, 2	2013-01-01
Substituted Aminothiazolone Indazoles As Estrogen Related Receptor-alpha Modulators App 20120302544 - Bignan; Gilles ; et al.	2012-11-29
Biphenyl Derivatives Useful As Glucagon Receptor Antagonists App 20120302641 - Chakravarty; Devraj ; et al.	2012-11-29
Picolinamido-propanoic Acid Derivatives Useful As Glucagon Receptor Antagonists App 20120302610 - Chakravarty; Devraj ; et al.	2012-11-29
Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators Grant 8,263,781 - Bignan , et al. September 11, 2	2012-09-11
Substituted Pyrimidinyl Oxime Kinase Inhibitors App 20120157412 - Battista; Kathleen A. ; et al.	2012-06-21
Substituted pyrimidinyl oxime kinase inhibitors Grant 8,153,791 - Xu , et al. April 10, 2	2012-04-10
Alkylquinoline and alkylquinazoline kinase modulators Grant 8,071,768 - Baindur , et al. December 6, 2	2011-12-06
SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS App 20110294780 - Bignan; Gilles ; et al.	2011-12-01
SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-a MODULATORS App 20110237625 - Gaul; Michael ; et al.	2011-09-29
Substituted pyrimidine kinase inhibitors Grant 8,013,153 - Butler , et al. September 6, 2	2011-09-06
Aminothiazolones As Estrogen Related Receptor-alpha Modulators App 20110200587 - Bignan; Gilles ; et al.	2011-08-18
Aminothiazolones As Estrogen Related Receptor-alpha Modulators App 20110200586 - BIGNAN; Gilles ; et al.	2011-08-18
Substituted Aminothiazolone Indazoles As Estrogen Related Receptor-alpha Modulators App 20110150864 - BIGNAN; Gilles ; et al.	2011-06-23
Hydrazone derivatives as kinase inhibitors Grant 7,893,064 - Xu , et al. February 22, 2	2011-02-22
Substituted phenoxy thiazolidinediones as estrogen related receptor-.alpha. modulators Grant 7,846,953 - Gaul , et al. December 7, 2	2010-12-07
Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis Grant 7,825,244 - Baindur , et al. November 2, 2	2010-11-02
Substituted phenyl acetamides and their use as protease inhibitors Grant 7,550,474 - Kreutter , et al. June 23, 2	2009-06-23
SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-alpha MODULATORS App 20090111855 - Gaul; Michael ; et al.	2009-04-30
Hydrazone Derivatives As Kinase Inhibitors App 20080114004 - Xu; Guozhang ; et al.	2008-05-15
Substituted Pyrimidinyl Oxime Kinase Inhibitors App 20070270425 - Xu; Guozhang ; et al.	2007-11-22
Substituted Pyrimidine Kinase Inhibitors App 20070254896 - Butler; Jeannene ; et al.	2007-11-01
Intermediates Useful In The Synthesis Of Alkylquinoline And Alkylquinazoline Kinase Modulators, And Related Methods Of Synthesis App 20070021436 - Baindur; Nand ; et al.	2007-01-25
Aminopyrimidines As Kinase Modulators App 20070021435 - Gaul; Michael David ; et al.	2007-01-25
Aminoquinoline And Aminoquinazoline Kinase Modulators App 20070004763 - Baindur; Nand ; et al.	2007-01-04
Aminopyrimidines As Kinase Modulators App 20060281764 - Gaul; Michael David ; et al.	2006-12-14
Alkylquinoline And Alkylquinazoline Kinase Modulators App 20060281772 - Baindur; Nand ; et al.	2006-12-14
Substituted phenyl acetamides and their use as protease inhibitors App 20040254166 - Kreutter, Kevin D. ; et al.	2004-12-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.